U.S. FDA Issues Guidances to Spur First-In-Human Studies

International Medical Device Regulatory Monitor
A A
The U.S. Food and Drug Administration (FDA) proposes to streamline device clinical trials in a pair of draft guidances outlining requirements for early feasibility studies and explaining when a trial can begin even when there are outstanding issues with an Investigational Device Exemption (IDE) submission.

To View This Article:

Login

Subscribe To International Medical Device Regulatory Monitor

Buy This Article Now

Add this article to your cart for $40.00